Research

Human Stem Cell and Neuronal Differentiation Core

Master
Heading

About the Core

Content

The ATC Human Neuronal Differentiation and Stem Cell Core is located at the Jan and Dan Duncan Neurological Research Institute. The service list of the core is extensive but focused on production of patient specific induced pluripotent stem cells, gene editing in human pluripotent stem cells, distribution and quality control of produced lines. The core operates under guidelines for BCM Institutional Advanced Technology Cores (ATC) in coordination with NRI/TCH procedures.  The Director of the merged core is Aleksandar Bajic, Ph.D. and requests for services can be made on iLabs

Heading

Hands-On Training

Content

We provide intensive hands-on training on human pluripotent stem cell culture for Baylor College of Medicine, MD Anderson, and other Texas Medical Center investigators. View class information.

Heading

Human Stem Cell Services

Content

The HSCC offers cost-effective solutions to generate and characterize novel human induced pluripotent stem (iPS) cells for in vitro disease modeling, employing “zero-footprint” technologies. View our services.

Heading

Terms and Conditions for use of Core

Content

View and download the form.

Heading

Information for Acknowledgement of Cores in Publications

Content

Core Name: Human Stem Cell Core  
Personnel: Aleksandar Bajic, Ph.D., Core Director; Hyekyung Park and Anel LaGrone, Research staff 
Grants: NIH P30 CA125123 Shared Resource (PI: Osborne) and NIH S10 OD028591 (PI: Kim)

Heading

Cells and Quality Control Testing

Content

The HSCC provides a reliable and well characterized source of undifferentiated human ES cells and iPS cells. See more information.

Heading

Major Products and Services

Content
  • Hands-on training classes and workshops
  • Consultation on experimental design
  • Human pluripotent stem cell (hPSC) culture services
  • Generation of induced pluripotent stem (iPS) cell lines
  • Stem cell line characterization (karyotyping and trilineage differentiation)
  • Mycoplasma testing
  • Customized genome editing of hPSCs using CRISPR/Cas9
Back to topback-to-top